Aim: To assess the role of doctors who patients report as responsible of their disease, in moderate-severe chronic obstructive pulmonary disease (COPD), describing characteristics of patients and treatments use according to each type of doctor, and relating it to the way of access to hospital at the time of an exacerbation. Materials/patients and methods: A systematic sample of 1:2 patients admitted for a COPD exacerbation during 1 year in four tertiary hospitals in the Barcelona area, Spain, was recruited. Information about health services was obtained by an administered questionnaire. Results: A total of 346 patients were recruited: mean age 69 (79) years, percent of predicted FEV 1 of 35 (716)%, PO 2 of 64 (713) mmHg. At the time of admission, 17% of patients reported being controlled by a general practitioner (GP) and 56% by a pneumologist whereas 21% reported its COPD not being under the regular control of any doctor. Patients not controlled by a pneumologist did not suffer from milder COPD than the remaining, but were less likely to receive pharmacological and nonpharmacological treatments and less likely to perform correctly the inhalation manoeuvres. During the course of the exacerbation 70% of patients reported a visit to a hospital emergency room department without a previous medical visit, this proportion being higher among those controlled by a pneumologist. Conclusions: Lack of control and variability in the patterns of care among patients controlled by different types of physicians are common in moderate-to-severe COPD patients admitted for a COPD exacerbation, despite the lack of differences in COPD severity. Medical control of COPD patients needs more investigation and a wider inclusion in international guidelines.
Introduction
Acute exacerbations during the course of the chronic obstructive pulmonary disease (COPD) are one of the most important causes of hospital admission in western countries, mainly during the winter period. 1, 2 Exacerbations and, specially, admissions due to exacerbation, have a large impact on quality of life, 3 increase the mortality, 4 and involve a large economic cost. Exacerbations of COPD are considered to be responsible of more than 35% of the global cost of COPD care. 5 Furthermore, increased winter emergency admissions disrupt elective admissions directly affecting waiting lists, 6 saturating emergency rooms (ERs) and not uncommonly inducing episodes of social concern with high echoing in the media. The importance of the economic and clinical consequences of COPD has fostered the research on new modalities of clinical management of COPD exacerbation, chiefly home delivered. 7 However, most COPD guidelines do not provide recommendations for the appropriate provision of current health services to patients. Although the 1995 ATS statement provided an indication of when a COPD patient should be controlled for a respiratory specialist, 8 to our knowledge, no research has been done to assess differential characteristics and effects of control by each type of physician in COPD patients. Two manuscripts, written in Dutch, were partly devoted to this issue in asthma and chronic bronchitis patients, 9 ,10 but their results can not be extrapolated to COPD.
In the EFRAM study we carried out an extended search of risk factors of hospital admission by a COPD exacerbation and included a wide assessment of how moderate and severe COPD patients were being controlled for their disease. 11, 12 In the present manuscript we focus on the role of doctors who patients reported as responsible of their COPD, describing characteristics of patients and treatments use according to each type of doctor, and relating it to the way of access to hospital at the time of an exacerbation.
Methods

Design and subjects
Descriptive study of a cross-sectional systematic sample of 1 out of every 2 patients hospitalised or remaining in the ER for at least 18 h for a COPD exacerbation in four tertiary hospitals in the Barcelona area over the recruitment year (from May 1, 1997 to April 30, 1998). [11] [12] [13] Patients were allowed to enter the study as many times as they were hospitalised during the recruitment period, resulting in 346 individuals with 404 admissions. For the present analysis, in patients with more than one admission during the recruitment period, the first one was selected.
COPD diagnosis was established by the ward pulmonologist and based on medical history, current symptoms and available pulmonary function tests, following the ERS guidelines.
14 An exacerbation was defined when the patient reported an increase in dyspnea, in sputum production or sputum purulence. 15 Recruitment methods and diagnosis criteria have been detailed in previous papers.
11 -13 The Ethics Committees of the participating hospitals approved the protocol, and written informed consent was obtained from all patients.
Measures
During the recruitment hospital admission, patients were asked to complete a questionnaire including a wide range of variables that have been detailed previously. 11 Weight, height and tricipital skinfold thickness were measured. At least 3 months after admission, and during a clinically stable period of COPD, patients performed a forced spirometric test and provided arterial blood samples to measure gas tensions. For the present analysis, we used information on sociodemographic and clinical factors, as well as on characteristics of received medical care-as reported by the patient-in the year prior to the recruitment admission. Patients were asked about the physician (general practitioner (GP), pneumologist of primary care, or pneumologist of hospital outpatient clinics) who they feel was responsible of controlling COPD. The question ' ' Who is, in your opinion, the most important doctor in treatment and control of your respiratory problems?'' was developed ad hoc for this study and piloted for understanding and feasibility in 81 hospitalised COPD patients. Other questions included: number of visits to this physician, number of hospital admissions due to COPD, current pharmacological treatment (b 2 -agonists, anticholinergics, methilxanthines, and inhaled and oral corticosteroids) and non-pharmacological treatment (influenza and pneumococcal vaccination, respiratory rehabilitation and long-term oxygen therapy). A detailed description of the contacts with the health care system between the onset of symptoms and the admission to the hospital (via ER) was also obtained, and patients were classified into two pathways: nonreferred emergency-room visit-in the case of patients who went straight to hospital when symptoms appeared-or referred emergency-room visit -in the case of patients who had been visited by a doctor first. Whenever possible, questions were adapted from the Health Interview Survey in Barcelona. 16 Detailed information about all the remaining variables, sources of questions and methods for spirometry and blood gas measures is available in previous papers. 11, 12 A relapse was defined as a readmission for a COPD exacerbation within 30 days of discharge. Information on re-admissions was obtained from a national administrative database, as has been described previously. 12 Vital status was ascertained through a record linkage with the Catalonia Mortality Registry, as previously reported. 12 
Statistical analysis
Comparison of patients' sociodemographic, clinical and medical care characteristics according to ' ' type of physician who controls the disease'' was performed with ANOVA (for quantitative variables of normal distribution), Kruskal-Wallis test (for quantitative variables of non-normal distribution) or w 2 (for qualitative variables). Proportions and 95% confidence intervals of drug and non-drug treatments were calculated from logistic regression estimates, adjusting for FEV 1 , PO 2 and previous COPD admissions. Logistic regression models were used to assess which factors are independently associated with non-referred emergency-room visits. Factors associated with length of stay were assessed using Poisson regression model. Time from discharge to relapse was used as the outcome variable in a Cox proportional hazards multivariate model to obtain variables independently associated with the relapse. The analysis was performed with Stata, release 8.0 (StataCorp, 2003, College Station, TX, USA).
Results
Most patients reported being controlled by a pneumologist, in the primary care setting (11%) or in the outpatient clinics (45%). One out of five patients did not identify any doctor responsible of their respiratory disease. Sociodemographic, clinical and medical care characteristics of patients in stability, according to type of physician who controls the disease are shown in Table 1 . Patients controlled by the outpatients pneumologist were younger, and exhibit lower PO 2 and higher PCO 2 values than the remaining. Patients treated by the pneumologist, both in primary care and outpatient setting, had suffered previous COPD admissions in more proportion than the remaining, and presented lower FEV 1 /FVC values, without differences in FEV 1 . Among patients who did not identify a responsible doctor there was a lower proportion of married, a higher proportion of current smokers, and COPD was milder than in the remaining subjects-according to values of FEV 1 , FEV 1 /FVC, PO 2 , and PCO 2 -although 65% of them had suffered at least one previous COPD admission. Patients controlled by the GP had a higher number of annual control visits than those controlled by pneumologist, while the latter had better performance of the inhaler manoeuvre. There were no differences in knowledge about the disease or in satisfaction with doctor.
Regarding the prescription of treatments for COPD, Table 2 shows that, after adjusting for severity (FEV 1 , PO 2 , and previous COPD admissions), patients controlled by the pulmonologist (9) 71 (11) 73 (7) 68 (9) 69 ( 
Clinical factors
Smoking Current, n (%)
86 (27) 22 (37) 6 (16) 24 (16) 34 (48) o0.0001
Ex, n (%)
214 (66) 31 (53) 32 (84) 117 (76) 34 (48) Never, n (%)
22 (7) 6 (10) 0 (0) 13 (8) 3 (4) Dyspnea at rest (continuous Visual Analogue Scale), m (SD) 
0 (0) 1 (3) 0 (0) 5 (9) o0.0001
IIa. FEV 1 50-79%, n (%)
36 (12) 5 (10) 4 (11) 12 (9) 15 (27) IIb. FEV 1 35-49%, n (%)
71 (25) 10 (21) 8 (22) 31 (23) 17 (30) III. FEV 1 o35%, n (%)
176 (61) 33 (69) 23 (64) 92 (68) 19 ( 
64 (13) 66 (11) 67 (14) 61 (12) 68 (13) 0.005
46 (9) 44 (7) 45 (9) 48 (9) 42 ( 
0.458
Health-services use and other medical-care related variables
At least one previous COPD admission, n (%)
279 (81) 40 (68) 33 (85) 142 (92) 48 (65) o0.0001
Number of visits to responsible doctor in the previous year, m (SD)
4 (3) 6 (4) 4 (3) 4 (3) Non applicable 0.006
Any medical visit for respiratory problems in the previous year, n (%)
256 (79) 59 (100) 39 (100) 155 (100) 5 (7) o0.0001
Unable to self-label the disease (whatever the setting) had a higher prevalence of drug and non-drug prescriptions, the difference being especially higher for inhaled corticosteroids, influenza vaccination and long-term oxygen therapy. The proportion of subjects without any respiratory drug treatment was higher in those controlled by the GP and those not controlled by any doctor. Following the onset of symptoms, 30% of patients were first visited by some doctor (whether in primary care, hospital outpatient clinics, as a home emergency, or others) and afterwards referred to the ER, whereas the remaining 70% attended directly the ER (non-referred ER visit) ( Table 3 ). The group being more likely to have consulted a doctor prior to attending the ER were those controlled by the GP. In a multivariate model, the only factors independently associated with non-referred ER visit were: a higher number of COPD admissions in the previous year (HR 1.36, 1.14-1.62), and being controlled by a pneumologist (HR 2.81, 1.50-5.25) or by no doctor (HR 2.01, 0.97-4.13) in comparison with GP.
Median time between the onset of symptoms (when the exacerbation appeared) and arrival to hospital was 6 days, statistically higher in those controlled by the GP (Table 3) , and in those who were first visited by a doctor (7 days vs. 5 days, P ¼ 0:02). Median hospital stay was 9 days. While there was not a difference in hospital stay according to the physician who controls the disease, those patients who were first visited by some doctor had a longer hospital stay (median 11 days vs. 8 days, P ¼ 0:05), as well as those with a longer period (X6 days) between the onset of symptoms and the admission (median 10 days vs. 8 days, P ¼ 0:01).
Six patients (2%) died during the recruitment admission and, during the 30 days following discharge, 34 (10%) died without having had a subsequent admission. Among the remaining (n ¼ 306), 66 (19%) presented a relapse (re-admission within 30 days). The type of doctor who controls COPD, a shorter length of stay, or other medical care related factors, were not associated with relapse in the Cox multivariate model. The Cox model including as the outcome both relapses and deaths in the 30 days following discharge yielded the same results.
Discussion
COPD is a leading cause of morbidity and mortality with a high economical cost due to frequent hospital admissions and intensive follow-up at tertiary hospitals. 5 An appropriate control of the disease is needed to reduce its associated burden. Our results, from a large cohort of moderate-tosevere COPD patients recruited systematically in four large university hospitals, showed that the type of physician controlling the COPD patients is related to substantial heterogeneity in the prescription of treatments and in the ways of access to hospital, even after adjusting for severity.
ARTICLE IN PRESS
The first relevant finding of the present study was that 21% of moderate-to-severe COPD patients admitted to a hospital by an exacerbation reported not being controlled regularly by any physician. Although all the subjects in Spain have universal access to health services, including an assigned GP, a proportion of patients failed to identify a physician whom they may feel is responsible of controlling their respiratory disease. Since some of these subjects were taking drugs or using oxygen therapy, it is obvious that they had had at a given period some control by a doctor over COPD. But considering that only 7% of these subjects reported any visit to a doctor for respiratory symptoms in the year prior to recruitment as compared to the 100% of all other groups, they likely experience a lack of control of their disease. The higher prevalence of current smokers and the lower prevalence of married among this group of subjects, may suggest a self-selected undercontrol of the disease. However, it is important to stand out that these patients were less likely to receive influenza vaccination, performed inhaled manoeuvres less well, had lower access to respiratory rehabilitation, and received less pharmacological treatment. Previous studies have reported a high prevalence of under treatment in COPD. [17] [18] [19] Since most of the later were performed in the general population it is reasonable to believe that most of the undertreatment is related to mild COPD. Our study shows that undertreatment is as well common among moderate and severe patients who require hospital admissions, providing additional evidence for concern about the current patterns of health care in COPD. 20 A second relevant finding is that a substantial proportion of these moderate-to-severe patients reported not being controlled by a pneumologist. Is the fact of not being controlled by a pneumologist a relevant issue? Since no evidence is available from clinical trials, observational studies may provide some useful information. In our study, patients controlled by the GP were not milder than those controlled by the pneumologist, contrarily to what could have been expected according to ATS recommendations. 8 One could argue that, apart 
Medical visit prior to hospital admission when the exacerbation appeared, n (%)
105 (30) 31 (53) 7 (18) 40 (26) 25 (34) o0.0001
Days from onset of symptoms to hospital admission, median (P25-P75) Relapse (re-admission in 30 days), n (%)
66 (19) 8 (14) 10 (26) 31 (20) 10 (14) 0.289 Ã 19 subjects were not included in the following stratification because other types of health-related professionals controlled them. For this reason, percentages do not sum up to 100%.
from lung function, other factors, such as hospital admissions, play a role in having contact with specialists. However, 25% of those controlled by GP reported two or more hospital admissions due to a COPD exacerbation in the previous year. Other countries have reported that differences in socioeconomic status and in health insurance schemes are responsible of differences in utilisation of GP or outpatient specialists. 21 Irrespectively of the reasons leading subjects to be controlled by one or another physician, our data show that, even after taking into account COPD severity, patients controlled by the GP had a lower prevalence of drug and non-drug treatments. Thus, it is probably needed that COPD guidelines include whether COPD patients should be cared by GP or by a specialist, as well as the development and compliance with COPD guidelines specific for GPs, with the final aim of a better control of COPD in the population.
Thirdly, we were interested in assessing the influence of the doctor who controls the disease in the hospital admission route when a COPD exacerbation occurs. In our area, and probably in most European countries, due to the increasing saturation of hospital beds and its associated high cost, health authorities use to make a strong emphasis on the need of consulting the GP before going to an ER. 1, 2 Our data show that more than two-thirds of COPD patients admitted in a tertiary hospital for an exacerbation had acceded to the ER from where they were admitted without a previous medical visit. We were able to assess which factors were associated to a direct access to hospital and found that only being controlled by a GP prevented such way of access. The fact that sociodemographic factors had no influence on the admission pathway suggests a good public health care system. The question is whether, at the time of a COPD exacerbation, a medical visit by the GP prior to access to the hospital ER reduces the probability of a subsequent admission. Wilkinson et al. 22 found that early therapy-in COPD subjects who consulted a physician when the exacerbation appeared-reduced recovery time and risk of further hospitalisation, in a panel of 128 moderate COPD patients. By contrast, we found that having been visited by a doctor during the course of the exacerbation, increased the time between onset of symptoms and admission to hospital, and was also associated with an increased length of stay, which may suggest that different severity of exacerbation requires from different health care pathways. Both studies are coincident in the importance of early intervention during a COPD exacerbation. It seems reasonable to propose that an early consultation to the GP should be advised.
To which extent in more severe patients an early hospital admission would be a better alternative requires further investigation. Unfortunately, health care alternatives such as early discharge programs, home hospitalisation, self-management plans or case-manager support were hardly available during the recruitment period in our area, thus not being possible to investigate their possible effect.
Several limitations of our study deserve further consideration. One is the cross-sectional design of our analysis. Information about health care before the hospital admission was obtained by questionnaire and information bias cannot be excluded. However, we restricted our questions to the period of time ranging from the onset of the exacerbation to the hospital admission, which should make a bias less likely. By contrast, self-reported information about the type of physician who controls the disease could involve misclassification. We are not aware about any study that had investigated the validity of self-reported information about the responsible physician in chronic conditions, a concept from which content validity may involve some difficulties. Other limitations like the presence of indication bias or the representativeness of our sample have been largely discussed in previous publications of the EFRAM study. [11] [12] [13] WHO has recently proposed that coordinate and comprehensive systems of health care should be adopted for complex health problems, such as chronic diseases. 23 Our study has shown that lack of control and variability in the patterns of care among patients controlled by different types of physician are common in moderate-to-severe COPD patients admitted for a COPD exacerbation, despite the lack of differences in COPD severity. These results provide an additional support to the necessity of fostering integral attention and continuity of care, as has been claimed for many other chronic conditions. 24 
